OESTROGEL

This brand name is authorized in Hong Kong SAR China, Ireland, Israel, Malta, Netherlands, Romania, Singapore, UK.

Active ingredients

The drug OESTROGEL contains one active pharmaceutical ingredient (API):

1
UNII CXY7B3Q98Z - ESTRADIOL HEMIHYDRATE
 

Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.

 
Read more about Estradiol

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
G03CA03 Estradiol G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA03
L02AA Estrogens L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents
Discover more medicines within L02AA

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
GB Medicines & Healthcare Products Regulatory Agency 139416, 146670, 162165, 165854, 176141, 34161
HK Department of Health Drug Office 34023
IE Health Products Regulatory Authority 24550
IL מִשְׂרַד הַבְּרִיאוּת 2901
MT Medicines Authority AA1173/06301, AA1173/06302, AA770/16901
NL Z-Index G-Standaard, PRK 200441
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W55402001
SG Health Sciences Authority 06503P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.